Oxidative phosphorylation inhibitors can inhibit the recurrence of KRAS‐mutant PCA,104 and ATO, an oxidative phosphorylation inhibitor,105 may inhibit the recurrence of PCA. Here, KRAS is linked to posterior cortical atrophy.